Aims/hypothesis In obesity oxidative stress is thought to contribute to the development of insulin resistance, non-alcoholic fatty liver disease and the progression to non-alcoholic steatohepatitis. Our aim was to examine the precise contributions of hepatocyte-derived H 2 O 2 to liver pathophysiology.
Introduction
Obesity is a major risk factor for the development of insulin resistance, a key factor in the aetiology of the metabolic syndrome and type 2 diabetes [1] [2] [3] . Obesity and insulin resistance promote the development of non-alcoholic fatty liver disease (NAFLD), which in a subset of individuals can progress to non-alcoholic steatohepatitis (NASH) [4] . NASH is characterised by fatty liver and overt inflammation that can lead to the death of steatotic hepatocytes, instigating reparative responses that result in fibrosis [4] . Oxidative stress accompanying the obese state is considered a key factor in the development of insulin resistance [5] [6] [7] and an important contributor to the development of NAFLD and NASH [4, [8] [9] [10] . Systemic and hepatic oxidative stress is evident in obesity and there is direct evidence for the involvement of reactive oxygen species (ROS) in the promotion of insulin resistance, NAFLD and NASH in obesity/type 2 diabetes in rodents [5] [6] [7] [8] [9] [10] [11] [12] [13] .
Mitochondria are thought to be the primary contributors to oxidative stress in obesity. Superoxide (O 2 • -) is a natural byproduct of the single-electron transport chain [14, 15] . In obesity, the chronic uptake and oxidation of energy substrates is thought to generate reducing equivalents that exceed the rate of ATP utilisation, thus enhancing the generation of O 2 • - [14, 15] . In addition, anaplerotic/cataplerotic pathways in hepatocytes in NAFLD induce mitochondrial O 2 • -generation and inflammation [9] , whereas in NASH, increased NADPH oxidase (NOX)-4 expression may also contribute to hepatic oxidative stress [8] . O 2 • -is converted to H 2 O 2 by superoxide dismutase (SOD) and thereafter eliminated by antioxidant enzymes such as catalase, peroxiredoxins (PRDXs) and glutathione peroxidase (GPX) [14, 15] . Oxidative stress ensues when the production of O 2 • -/H 2 O 2 exceeds the antioxidant capacity of a cell.
Transient, localised H 2 O 2 generation can occur in response to physiological stimuli such as growth factors and hormones [14] . Both NOX and mitochondria have been implicated in the generation of O 2 • -and H 2 O 2 in response to physiological stimuli [14, 16, 17] . An increase in H 2 O 2 in response to stimuli such as insulin can facilitate signalling by oxidising and inactivating protein tyrosine phosphatases (PTPs) [18] . Several PTPs, including the tyrosine-specific PTP1B and the dual-specificity phosphatase and tensin homologue, can be oxidised in response to insulin to promote insulin receptor (IR) activation and downstream phosphatidylinositol 3-kinase (PI3K) signalling, respectively [16, [19] [20] [21] [22] . GPX1 is a ubiquitous selenoenzyme that uses glutathione to catalyse the conversion of H 2 O 2 into H 2 O [18] . Gpx1 -/-mice are healthy and fertile and do not show any obvious abnormalities [23, 24] . Indeed, when Gpx1 -/-mice are fed a high-fat diet that promotes moderate adiposity and insulin resistance, but not hyperglycaemia [25] , GPX1 deficiency promotes insulin signalling in muscle and protects mice from the development of insulin resistance [22] , indicating that increases in H 2 O 2 in muscle may be beneficial. Moreover, even in the context of morbid obesity and hyperglycaemia, global GPX1 deficiency protects mice from the development of steatohepatitis and liver damage and improves glucose metabolism [25] . Given the extensive tissue crosstalk in the control of glucose and lipid homeostasis and the capacity of H 2 O 2 to diffuse across membranes, it is difficult to definitively ascribe the effects of global GPX1 deficiency and heightened H 2 O 2 on hepatic pathophysiology to any cell type or tissue and to exclude potential detrimental effects being masked by the global deletion of GPX1. Therefore we have 'floxed' the Gpx1 allele to allow us to explore the hepatocyte-specific contributions of GPX1 to the regulation of hepatic insulin sensitivity and the development of NAFLD and NASH.
Methods
Mice Gpx1 lox/+ mice on a C57BL/6 J background were generated by the Monash Gene Targeting Facility as described in electronic supplementary material (ESM) Methods. Alb-Cre (C57BL/6 J) mice have been described previously [13] . Mice were maintained on a 12 h light-dark cycle in a temperaturecontrolled high-barrier facility with free access to food (6% wt/wt fat) and water. Where indicated, mice were fed an obesogenic diet (23.5% wt/wt fat, SF04-027; Specialty Feeds, Glen Forest, WA, Australia) or a choline-deficient amino-acid-defined (CDAA) diet (SF13-103; Specialty Feeds). Experiments were conducted on age-matched male mice and experimentors were blind to outcome assessment. Experiments were approved by the Monash University Animal Ethics Committee.
Metabolic analyses Blood was collected for analysis of fed and fasted blood glucose and plasma insulin as described previously [22] . Insulin and pyruvate tolerance tests were performed in mice fasted for 4-6 h and hyperinsulinaemiceuglycaemic clamps were performed as described previously [22] . Other metabolic analyses and NASH scoring are described in ESM Methods.
Biochemical analyses Tissue homogenates were analysed as described previously [22] . Immunoblotting antibodies are described in ESM Methods. Hepatic glycogen was extracted and debranched with amylo-α-l,4-α-1,6-glucosidase and glucose units were analysed using an enzymatic fluorometric method described previously [26] .
For the analysis of PTP oxidation, frozen liver samples were homogenised under anaerobic conditions in the presence of N-ethylmaleimide to alkylate all reduced PTPs and then subsequently reduced and hyperoxidised to the sulfonic state as described previously [13] . Immunoblots were probed with a mouse monoclonal antibody (PTPox) raised against the signature motif of the prototypic PTP1B oxidised to the irreversible sulfonic state, which detects tyrosine-specific PTPs oxidised to the sulfonic state [27] .
Total and oxidised glutathione levels in tissue supernatant fractions or blood were measured as described previously [25] .
H 2 O 2 measurements Hepatocytes were isolated using a twostep collagenase A perfusion method [13, 28] . Hepatocytes were serum-starved in low-glucose DMEM (ThermoFisher, Waltham, MA, USA) containing 0.1% (vol./vol.) FBS for 2 h and incubated in PBS containing 100 μmol/l Amplex Red reagent and 1 U/ml HRP ( A m p l e x R e d h y d r o g e n p e r o x i d e a s s a y k i t ; ThermoFisher) in the presence or absence of 100 nmol/l insulin and fluorescence measured and normalised to protein.
Quantitative PCR Hepatic levels of Gpx1, Gpx3, Gpx4, Ho1 (also known as Hmox1), Txn1, Trxrd1 (Txnrd1), G6pc, Pck1, Gck, Pdk4, Lpk (Col2a1), Ppargc1α (Ppargc1a), Cpt1, Acadl, Srebp1c (Srebf1), Fasn, Saa1, Crp, Il1α (Il1a), Ifnγ (Ifng), Il6, Tnf, Mcp-1 (Ccl2), αSma (Acta2) and Tgfβ (Tgfb1) were assessed by quantitative real-time PCR (ΔΔC t ) performed using the TaqMan Universal PCR Master Mix and TaqMan Gene Expression Assays (ThermoFisher Scientific) as described previously [13] .
Statistical analyses Analyses were performed using the twotailed Student's t test or ANOVA. A p value of < 0.05 was considered significant (*p < 0.05, **p < 0.01, ***p < 0.001).
Results
Hepatocyte-specific GPX1-deficient mice We generated a floxed allele of Gpx1 (Fig. 1a-c ; C57BL/6) alone caused a reduction in GPX1 protein in epididymal fat and gastrocnemius muscle (Fig. 1d,e) , which express low amounts of GPX1, but not in liver (Fig. 1f) , where GPX1 expression is abundant. The reduction in GPX1 in fat or muscle did not result in systemic oxidative stress when GPX1-deficient mice were compared with C57BL/6 wild-type mice, as assessed by measuring reduced (GSH) and oxidised (GSSG) glutathione levels in blood and reflected by an unaltered GSH:GSSG ratio (a reduced ratio being indicative of oxidative stress; Fig. 2a) . Moreover, the reduction in GPX1 in muscle of Gpx1 lox/lox (lox/lox) mice did not result in increased H 2 O 2 when compared with C57BL/6 wild-type mice, as assessed using the H 2 O 2 selective probe Amplex Red (Fig. 2e) . Similarly, the reduction in GPX1 in fat or muscle did not result in oxidative stress as assessed by measuring GSH and GSSG levels ( Fig. 2c,d ). Therefore the remaining GPX1 protein in lox/lox mouse tissues such as adipose tissue or muscle is sufficient to prevent any increase in H 2 O 2 and the development of oxidative stress. To conditionally delete Gpx1 in hepatocytes, we bred lox/lox mice with those expressing the Alb-Cre transgene, which recombines floxed alleles in hepatocytes [29] . GPX1 protein expression was specifically ablated in livers from 10-week-old Alb-Cre;Gpx1 lox/lox hepatocytespecific Gpx1-knockout (HGKO) mice; this was not the case in other tissues including muscle and epididymal fat ( Fig. 1d-f ). Any remaining GPX1 in HGKO livers reflected that present in non-parenchymal cells, as no GPX1 protein was detected in hepatocytes from HGKO mice (Fig. 1f) . Hepatic GPX1 deficiency did not result in compensatory increases in Gpx2, Gpx3 or Gpx4, or alterations in Txn1 (encoding thioredoxin), Trxrd1 (encoding thioredoxin reductase) or Ho1 (encoding haem oxygenase-1) (Fig. 1g) . Moreover hepatic GPX1 deficiency did not result in compensatory increases in catalase or PRDX1 in liver and fat, or altered PRDX1 expression in muscle ( Fig. 1d-f ). However, hepatic GPX1 deficiency was accompanied by decreased catalase in gastrocnemius muscle ( Fig. 1e) , pointing towards crosstalk between hepatocyte and muscle antioxidant capacity.
H 2 O 2 generation in HGKO mice At 4-10 weeks of age no differences were evident in body weight or body/tissue composition between lox/lox and HGKO mice (ESM Fig. 1a-c) . Food intake, oxygen consumption, ambulatory activity and energy expenditure were unaltered, as were respiratory exchange ratios, consistent with unaltered energy homeostasis and fuel utilisation (ESM Fig. 1d ). To determine whether hepatocyte GPX1 deficiency results in oxidative stress we monitored alterations in GSH and GSSG in blood or liver homogenates from chow-fed lox/lox and HGKO mice. No alterations were evident in blood or liver as a consequence of GPX1 deficiency (Fig. 2a,b) . Similarly, no changes in GSH or GSSG were evident in epididymal fat (Fig. 2c) . Interestingly total GSH and GSSG were elevated in muscle of HGKO mice, but the GSH:GSSG ratio was unaltered (Fig. 2d) , consistent with the increase in GSH being compensatory to counter any muscle oxidative stress that may otherwise occur as a result of decreased muscle catalase expression (Fig. 1e ). In keeping with this, (e) Blood glucose and plasma insulin levels from +/+ (grey bars, n = 10), lox/lox (black bars, n = 12) and HGKO (white bars, n = 11) mice. (f) Pyruvate tolerance test (2 mg/g) and insulin tolerance test (0.5 mU/g) from lox/lox (black squares; n = 9 and 12, respectively) and HGKO (white circles; n = 9 and 13, respectively) mice. AUCs were determined and arbitrary units (AU) are shown. (g) Hyperinsulinaemiceuglycaemic clamps in 10-weekold male fasted (4 h) lox/lox (black bars, n = 6) and HGKO (white bars, n = 5) mice. Glucose infusion (GIR) and disappearance (RD) rates and basal and clamped endogenous glucose production (EGP) were determined. Results are means ± SE. † p = 0.06 muscle H 2 O 2 levels were not altered (Fig. 2e) . To directly assess whether hepatic GPX1 deficiency results in increased H 2 O 2 , we isolated hepatocytes from chow-fed lox/lox and HGKO mice; we found that GPX1 deficiency resulted in increased hepatocyte H 2 O 2 production (Fig. 2f) . Therefore, GPX1 deficiency increases H 2 O 2 in hepatocytes but the levels do not exceed the antioxidant capacity of the liver and do not promote overt hepatic or systemic oxidative stress in chow-fed mice. (Fig. 3a) , accompanied by a 7.2-fold increase in Gck expression (Fig. 3a) ; GCK catalyses the conversion of glucose to G6P and serves as the first step in glycolysis or glycogen synthesis. In keeping with this, glycogen levels were increased in the livers of HGKO mice (Fig. 3b) . In addition, the expression of Pdk4 (encoding pyruvate dehydrogenase kinase-4, which is repressed by insulin and inhibits glucose oxidation) was decreased by 50% (Fig. 3a) . No differences were evident in Srebp1c and Fasn lipogenic gene expression (Fig. 3c ) or in hepatic steatosis as assessed by histology (Fig. 3d) . No changes were evident for Lpk (encoding pyruvate kinase, which catalyses the conversion of phosphoenolpyruvate to pyruvate) or for Ppargc1a (encoding proxisome proliferator-activated receptor γ-1α) and other mitochondrial genes involved in fatty acid oxidation (Fig. 3a) . These results are consistent with GPX1 deficiency enhancing the repression of HGP and promoting glucose storage and utilisation without effects on lipogenesis. We next examined glucose homeostasis in chow-fed C57BL/6 (+/+), lox/lox and HGKO mice. Although blood glucose levels of fed mice and mice fasted for 6 h remained the same, 12 h fasted blood glucose levels were significantly reduced in HGKO mice compared with +/+ or lox/lox mice (Fig. 3e) . The reduced blood glucose levels in mice fasted for 12 h is consistent with HGP being reduced in HGKO mice. No differences were observed in plasma insulin levels of fed mice (Fig. 3e) , consistent with unaltered pancreatic insulin secretion, but 12 h fasted plasma insulin levels were reduced, consistent with improved insulin sensitivity; no differences were observed between +/+ and lox/lox mice. To assess the effect on HGP we performed pyruvate tolerance tests; pyruvate increases blood glucose by promoting gluconeogenesis. Administration of pyruvate increased blood glucose in +/+ and lox/lox mice, but the increase was attenuated in HGKO mice ( Fig. 3f; ESM Fig. 2a ). Next we assessed insulin sensitivity in insulin tolerance tests. We found that insulin responses were moderately improved in HGKO mice (Fig. 3f) ; no differences were observed between +/+ and lox/lox mice (ESM Fig. 2b) . These results point towards hepatocyte-specific GPX1 deficiency repressing HGP and enhancing insulin sensitivity in chow-fed mice.
Glucose homeostasis in HGKO mice
To further characterise glucose homeostasis we subjected chow-fed lox/lox and HGKO mice to hyperinuslinaemiceuglycaemic clamps (Fig. 3g) . We found that the glucose infusion rate necessary to maintain euglycaemia was significantly increased in HGKO mice (Fig. 3g) , consistent with enhanced whole-body insulin sensitivity. Moreover glucose disappearance, which reflects hepatic and peripheral glucose metabolism, tended to be higher in HGKO mice than in lox/ lox mice (p = 0.06) (Fig. 3g) . Finally, the extent to which endogenous glucose production was suppressed by insulin tended to be higher in the HGKO mice (Fig. 3g) . These results indicate that hepatic GPX1 deficiency enhances insulin sensitivity by potentiating the suppression of gluconeogenic enzymes and by promoting hepatic glucose storage.
Insulin signalling in HGKO mice
In the liver insulin promotes glycogen synthesis by activating Akt, which phosphorylates and inhibits glycogen synthase kinase-3 that phosphorylates and inhibits glycogen synthase (GS). Akt also phosphorylates and inhibits forkhead box protein O1 (FOXO1), which promotes PEPCK and G6P and inhibits GCK expression [30] . We monitored for IR activation and downstream PI3K/Akt signalling in liver, epididymal fat and muscle in mice that had been fasted (4 h) and administered a bolus of insulin. Hepatic GPX1 deficiency enhanced basal IR-Y1162/Y1163 phosphorylation in fasted mice, but not insulin-induced IR phosphorylation (Fig. 4a) . Similarly GPX1 deficiency enhanced basal PI3K/Akt signalling, as assessed by Akt-S473 phosphorylation, but had no effect on insulin-induced Akt phosphorylation (Fig. 4a) . The activation status of other signalling pathways in fasted mice, including those mediated by STAT-3 (signal transducer and activator of transcription-3), ERK1/2 (extracellular signal-regulated kinases 1/2) and c-Jun N-terminal kinases (JNK) were not altered (ESM Fig. 3a ) and there were no overt changes in general tyrosine phosphorylation (ESM Fig. 3b ). In keeping with the increased basal PI3K/Akt signalling, FOXO1 Thr-24 phosphorylation was higher and GS Ser-640/Ser-641 phosphorylation lower in fasted HGKO mice (Fig. 4b) . The increased IR phosphorylation and PI3K/Akt signalling in 4 h fasted HGKO mice suggests that insulin signalling may be prolonged by GPX1 deficiency. In keeping with this, 12 h fasting IR and Akt phosphorylation were not altered (ESM Fig. 3c ). No differences were evident in basal or insulininduced IR or Akt phosphorylation in fat or muscle (ESM Fig. 3d) . To reaffirm the enhanced insulin signalling we compared responses in hepatocytes from lox/lox and HGKO mice. Hepatocyte basal and insulin-induced H 2 O 2 generation was exacerbated by GPX1 deficiency (Fig. 4c) . Moreover, insulininduced IR-Y1162/Y1163 and Akt-S473 phosphorylation was enhanced (Fig. 4d) . These results indicate that GPX1 deficiency enhances hepatic insulin-induced H 2 O 2 and insulin-induced IR activation and PI3K/Akt signalling to repress HGP and promote liver glucose storage or utilisation.
PTP oxidation in HGKO mice One mechanism by which the increased H 2 O 2 levels associated with GPX1 deficiency might enhance IR signalling and thereby improve hepatic glucose metabolism is through the oxidation and inactivation of PTPs involved in IR dephosphorylation. PTP oxidation was examined in livers from lox/lox and HGKO mice by immunoblot analysis (Fig. 5a,b ) and immunoblots were reprobed with antibodies to PTPs with corresponding molecular masses (Fig. 5c) . The oxidation status of PTPs (Fig. 5a,b) , including those comigrating with tyrosine-protein phosphatase non-receptor type 2 (TCPTP), PTP1B and small heterodimer partner (SHP)-1, implicated previously in IR desphosphorylation [31, 32] , was enhanced by GPX1 deficiency (Fig. 5b,c) . These results are consistent with the elevated H 2 O 2 in GPX1-deficient hepatocytes promoting the oxidation and inactivation of PTPs and hence insulin signalling and glucose homeostasis.
Oxidative stress in obese HGKO mice Obesity is characterised by oxidative stress and insulin resistance [5] [6] [7] . Accordingly, we determined whether hepatocyte GPX1 deficiency might exacerbate oxidative stress and insulin resistance in mice fed an obesogenic diet. Hepatic GPX1 deficiency did not alter body weight, adiposity (ESM Fig. 4a-c) , food intake, energy expenditure or ambulatory activity (ESM Fig. 4d ) after 12 weeks of high-fat feeding. Liver-specific GPX1-deficient Oxidative stress in HFF mice. Ten-week-old male lox/lox (black bars, n = 9) and HGKO (white bars, n = 10) mice were fed with a high-fat diet for 12 weeks.
(a-c) total GSH (tGSH), GSSG and normalised GSH:GSSG ratios in blood, liver and muscle.
(d) Hepatocytes were stimulated with PBS or insulin (100 nmol/l) and H 2 O 2 production measured in live cells (n = 3). Quantified results are means ± SE mice exhibited systemic oxidative stress as indicated by increased blood GSSG levels and decreased GSH:GSSG ratios (Fig. 6a) . When compared with lox/lox mice, no differences were evident in hepatic H 2 O 2 detoxification and redox gene or protein levels (ESM Fig. 5a ,b) and there were no differences in GSH or GSSG (Fig. 6b) , GPX1, catalase or PRDX1 in muscle (ESM Fig. 5c ). Interestingly, GSSG levels in the liver were decreased so that the GSH:GSSG ratio was increased (Fig. 6c) . Peroxide detoxification by GPX1 is reliant on GSH and results in the generation of GSSG. Hence the decrease in GSSG is in keeping with GPX1 being one of the major enzymes that uses GSH as an electron donor to generate GSSG. Despite the decreased liver GSSG, H 2 O 2 was markedly increased in hepatocytes isolated from high-fat-fed (HFF) HGKO vs lox/lox mice; this increase far exceeded that normally seen in response to insulin (Fig. 6d) . These results are consistent with hepatocyte GPX1 deficiency exacerbating hepatocyte-derived H 2 O 2 and promoting systemic oxidative stress in HFF mice.
Glucose homeostasis in obese HGKO mice We determined whether the systemic oxidative stress evident in HFF HGKO mice might exacerbate the development of insulin resistance and glucose intolerance. When comparing HGKO mice with lox/lox mice, although no differences were evident in blood glucose levels, fasted insulin levels were reduced (Fig. 7a) , consistent with improved insulin sensitivity. Moreover, although no differences were evident in insulin tolerance tests (Fig. 7b) , pyruvate responses were attenuated (Fig. 7c) and the expression of G6pc and Pck1 in the livers of fasted mice was reduced (Fig. 7d) , consistent with decreased gluconeogenesis. In keeping with this, GPX1 deficiency was accompanied by significantly increased insulin-induced phosphorylation of IR and Akt Ser-473 in the liver (Fig. 7e) . These results point towards hepatic GPX1 deficiency improving liver glucose homeostasis even in the context of obesity and systemic oxidative stress. Reduced inflammation and NASH in HGKO mice Hepatic oxidative stress has been linked with the development of NAFLD and NASH, the latter characterised by lymphocyte infiltrates, inflammation and liver damage [4, [8] [9] [10] [11] . We found that hepatocyte-specific GPX1-defiency in HFF mice was not associated with overt differences in steatohepatitis, as assessed by histology (Fig. 8a) or the expression of lipogenic genes (Fig. 8b) . Surprisingly, the enhanced hepatocytederived H 2 O 2 in HFF HGKO mice resulted in the decreased expression of genes associated with inflammation (Fig. 8c) . Since HFF C57BL/6 mice develop fatty liver, but not NASH, we sought to further explore the impact of GPX1 deficiency on the development of NASH and the associated inflammation and fibrosis in mice fed a CDAA diet for 12 weeks. The CDAA diet promotes weight gain, insulin resistance and key features of NASH, including steatosis, lymphocytic infiltrates and fibrosis [8] . Hepatic GPX1 deficiency did not alter body weight in CDAA diet-fed mice (ESM Fig. 6a ) and had no obvious effect on hepatic steatosis as assessed by histology (Fig. 8a) , or the expression of lipogenic genes (Fig. 8b) . Strikingly, GPX1 deficiency resulted in reduced lymphocytic infiltration in the liver and repressed hepatic inflammation, as (g) Plasma IFNγ, IL-6 and TNF levels were determined using a BD Cytometric Bead Array; for TNF, p = 0.06 for lox/lox vs HGKO mice fed a CDAA diet. Representative and quantified (means ± SE) results are shown assessed by histology ( Fig. 8d; ESM Fig. 6b ) and expression of acute-phase and pro-inflammatory genes (Fig. 8c) . Moreover, GPX1 deficiency markedly reduced fibrosis, as assessed by histology (PicroSirius Red collagen staining; Fig. 8e and ESM Fig. 6b) and expression of fibrogenic genes (Fig. 8f) . Finally CDAA-fed HGKO mice exhibited a significant reduction in systemic inflammation, as assessed by reduced circulating levels of IFNγ, IL-6 and TNF (Fig. 8g) . Therefore, GPX1 deficiency represses lymphocytic infiltration, inflammation and fibrosis in the liver, key diagnostic and pathological features of NASH.
Discussion
Global GPX1-deficient mice fed an obesogenic diet are protected from the development of steatohepatitis and ensuing liver damage [25] . Although this was previously attributed to decreased pancreatic insulin secretion and attenuated insulinmediated hepatic lipogenesis [25] , a hepatocyte-intrinsic contribution could not be excluded. Here, we confirm that hepatocyte GPX1 deficiency does not alter the development of steatohepatitis in mice fed either an obesogenic diet that promotes NAFLD or a CDAA diet that promotes NASH. Strikingly, despite the unaltered steatosis, hepatic GPX1 deficiency was associated with decreased hepatic and systemic inflammation and reduced liver lymphocytic infiltration and fibrosis in mice fed a CDAA diet. Although the molecular mechanism by which hepatocyte GPX1 deficiency may decrease inflammation and ensuing NASH remains to be resolved, one possibility is that this may be linked to increased PTP1B oxidation, since hepatic PTP1B deficiency represses hepatocyte endoplasmic reticulum stress and inflammation [33, 34] .
Altered oxidative phosphorylation and increased ROS levels are reported in patients with NASH [4, 11] and there is compelling evidence from rodent models linking oxidative stress with NAFLD or NASH [10, 35, 36] . Hepatocytespecific SOD1-deficiency or combined SOD1/2 deficiencies increase steatohepatitis in HFF mice [37, 38] . This is consistent with superoxide being important in the promotion of steatohepatitis and liver disease. In keeping with this, NOXs are elevated in models of fibrogenic disease [39] , whereas NOX1/4 inhibition or hepatocyte NOX4 deficiency protect mice against NASH [8, 40] . In contrast, a recent study has shown that the deletion of the haem oxygenase-1 gene in hepatocytes promotes the generation of H 2 O 2 and attenuates high-fat diet-induced insulin resistance and hepatic inflammation and damage [41] . Our findings also challenge the concept that hepatocyte-derived H 2 O 2 per se is a driver of liver disease.
We previously reported that global GPX1 deficiency promotes hepatic insulin signalling and repression of HGP in the obese state [25] . However, it was unclear whether these effects were intrinsic to hepatocytes or reflected reduced pancreatic insulin secretion [25] , since hyperinsulinaemia can drive insulin resistance [42] [43] [44] and reduction in circulating insulin can protect mice from diet-induced obesity, insulin resistance and steatosis [45] . In this study we found that insulin-induced H 2 O 2 generation and insulin signalling were increased in hepatocytes from HGKO mice, accompanied by increased hepatic IR activation and signalling even in the context of obesity. Why does GPX1 deficiency in HFF mice not promote insulin resistance? One argument could be that a sufficient level of H 2 O 2 was not achieved in hepatocytes. However, H 2 O 2 generation by hepatocytes isolated from HFF HGKO mice far exceeded levels normally achieved in response to insulin. We propose that either H 2 O 2 per se is not detrimental or that hepatic oxidative stress and the promotion of insulin resistance may also be reliant on contributions from nonparenchymal cells. In keeping with the latter premise, mice overexpressing PRDX4, a secreted enzyme that scavenges ROS, are protected from steatohepatitis [46] .
Reactive and potentially modulatory cysteines exist in many proteins [14, 15] . However, the low thiol pK a of the catalytic cysteine in PTPs renders them highly susceptible to oxidation and inactivation [18] . In this study we report that the oxidation of select hepatic PTPs, including PTP1B, SHP-1 and TCPTP, is increased in HGKO mice. Previous studies have established that PTP1B and SHP-1 can dephosphorylate the IR to regulate hepatic insulin sensitivity [31, 33, 47] . Similarly, heterozygous TCPTP deficiency enhances hepatocyte IR phosphorylation and represses HGP [28, 48] . We speculate that the oxidation of such PTPs would promote insulin signalling to regulate hepatic glucose metabolism, although we cannot exclude the contribution of other pathways given the growing number of metabolic proteins that can be oxidised, including pyruvate kinase M2 [49] and pyruvate kinase 2 [50] .
Our findings warrant a redress of the contributions of ROS such as H 2 O 2 to hepatic pathophysiology in obesity and suggest that increases in hepatocyte H 2 O 2 may in fact represent a compensatory and beneficial response to attenuate disease progression.
